Hafner, M.; Herold, T.R.; Kufner, A.; Eckardt, F.; Asani, B.; Priglinger, S.G.; Schiefelbein, J.
Extended Real-World Efficacy of Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: 9-Month Follow-Up Results. J. Clin. Med. 2025, 14, 7197.
https://doi.org/10.3390/jcm14207197
AMA Style
Hafner M, Herold TR, Kufner A, Eckardt F, Asani B, Priglinger SG, Schiefelbein J.
Extended Real-World Efficacy of Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: 9-Month Follow-Up Results. Journal of Clinical Medicine. 2025; 14(20):7197.
https://doi.org/10.3390/jcm14207197
Chicago/Turabian Style
Hafner, Michael, Tina R. Herold, Alexander Kufner, Franziska Eckardt, Ben Asani, Siegfried G. Priglinger, and Johannes Schiefelbein.
2025. "Extended Real-World Efficacy of Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: 9-Month Follow-Up Results" Journal of Clinical Medicine 14, no. 20: 7197.
https://doi.org/10.3390/jcm14207197
APA Style
Hafner, M., Herold, T. R., Kufner, A., Eckardt, F., Asani, B., Priglinger, S. G., & Schiefelbein, J.
(2025). Extended Real-World Efficacy of Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: 9-Month Follow-Up Results. Journal of Clinical Medicine, 14(20), 7197.
https://doi.org/10.3390/jcm14207197
